Advertisement

Insurers And Government Are Slow To Cover Expensive CAR-T Cancer Therapy

Some critically ill patients who received a CAR-T cell treatment have remained cancer-free for as long as five years, researchers say. But the price is high. (Collection Mix: Subjects RF/Getty Images)
Some critically ill patients who received a CAR-T cell treatment have remained cancer-free for as long as five years, researchers say. But the price is high. (Collection Mix: Subjects RF/Getty Images)

Related:

Advertisement

More from WBUR

Listen Live
Close